Related Experiment Video
Updated: Jun 9, 2026

Primary Microglia Isolation from Mixed Glial Cell Cultures of Neonatal Rat Brain Tissue
Published on: August 15, 2012
Neonatal Meningitis-Causing Escherichia coli Induces Microglia Activation which Acts as a Double-Edged Sword in
Yingying Su1,2, Guozhen Ma1,2, Yangyang Zheng1,2
1The Key Laboratory of Molecular Microbiology and Technology, Ministry of Education, Nankai University, Tianjin 300457, China.
Abstract:
Bacterial meningitis is a devastating disease occurring worldwide, with up to half of survivors left with permanent neurological sequelae. Neonatal meningitis-causing Escherichia coli (NMEC) is the most common Gram-negative bacillary organism that causes meningitis, particularly during the neonatal period. Here, RNA-seq transcriptional profiles of microglia in response to NMEC infection show that microglia are activated to produce inflammatory factors. In addition, we found that the secretion of inflammatory factors is a double-edged sword that promotes polymorphonuclear neutrophil (PMN) recruitment to the brain to clear the pathogens but, at the same time, induces neuronal damage, which may be related to the neurological sequelae. New neuroprotective therapeutic strategies must be developed for the treatment of acute bacterial meningitis. We found that transforming growth factor-β (TGF-β) may be a strong candidate in the treatment of acute bacterial meningitis, as it shows a therapeutic effect on bacterial-meningitis-induced brain damage. Prevention of disease and early initiation of the appropriate treatment in patients with suspected or proven bacterial meningitis are the key factors in reducing morbidity and mortality. Novel antibiotic and adjuvant treatment strategies must be developed, and the main goal for new therapies will be dampening the inflammatory response. Based on this view, our findings may help develop novel strategies for bacterial meningitis treatment.
Insights
Neonatal meningitis-causing Escherichia coli (NMEC) activates microglia, releasing factors that harm neurons. Transforming growth factor-beta (TGF-β) shows therapeutic potential for bacterial meningitis brain damage.
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Bacterial meningitis is a severe global disease with significant neurological sequelae.
- Neonatal meningitis-causing Escherichia coli (NMEC) is a primary cause of Gram-negative bacterial meningitis in newborns.
Purpose of the Study:
- To investigate microglial responses to NMEC infection.
- To explore the dual role of inflammatory factors in meningitis.
- To identify potential therapeutic targets for bacterial meningitis.
Main Methods:
- RNA-sequencing (RNA-seq) to analyze microglial transcriptional profiles.
- Assessment of inflammatory factor secretion and its effects on neutrophils and neurons.
Main Results:
- NMEC infection activates microglia to produce inflammatory factors.
- These factors aid pathogen clearance by recruiting neutrophils but also cause neuronal damage.
- Transforming growth factor-beta (TGF-β) demonstrated a protective effect against meningitis-induced brain injury.
Conclusions:
- Microglial-derived inflammatory factors have a dual role in bacterial meningitis, contributing to both defense and damage.
- TGF-β presents a promising therapeutic candidate for mitigating neuroinflammation and brain damage in bacterial meningitis.
- Developing novel strategies to modulate the inflammatory response is crucial for treating bacterial meningitis.
Related Concept Videos
Bacterial Meningitis
Bacterial Gastroenteritis
Viral Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction

